Brian Lenz
2015 - ADMA Biologics
In 2015, Brian Lenz earned a total compensation of $693.1K as Chief Financial Officer at ADMA Biologics, a 7% increase compared to previous year.
Compensation breakdown
| Bonus | $122,500 |
|---|---|
| Option Awards | $216,070 |
| Salary | $346,539 |
| Other | $7,950 |
| Total | $693,059 |
Lenz received $346.5K in salary, accounting for 50% of the total pay in 2015.
Lenz also received $122.5K in bonus, $216.1K in option awards and $8K in other compensation.
Rankings
In 2015, Brian Lenz's compensation ranked 9,565th out of 13,638 executives tracked by ExecPay. In other words, Lenz earned more than 29.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,565 out of 13,638 | 30th |
Division Manufacturing | 3,646 out of 5,187 | 30th |
Major group Chemicals And Allied Products | 1,334 out of 1,857 | 28th |
Industry group Drugs | 1,091 out of 1,531 | 29th |
Industry Biological Products, Except Diagnostic Substances | 191 out of 260 | 27th |
Source: SEC filing on April 29, 2016.
Lenz's colleagues
We found two more compensation records of executives who worked with Brian Lenz at ADMA Biologics in 2015.
News
ADMA Biologics CEO Adam Grossman's 2023 pay jumps 128% to $6M
April 15, 2024
ADMA Biologics CEO Adam Grossman's 2022 pay falls 39% to $2.6M
April 13, 2023
ADMA Biologics CEO Adam Grossman's 2021 pay jumps 122% to $4.4M
April 28, 2022
ADMA Biologics CEO Adam Grossman's 2020 pay rises 15% to $2M
April 7, 2021
ADMA Biologics CEO Adam Grossman's 2019 pay rises 10% to $1.7M
April 29, 2020
ADMA Biologics CEO Adam Grossman's 2018 pay falls 42% to $1.6M
April 24, 2019